Substance P and CGRP Drive the Severe Cough of Pulmonary Fibrosis
Increased expression of substance P, NK1R, and CGRP in lung tissue correlated directly with heightened cough sensitivity in a guinea pig model of idiopathic pulmonary fibrosis.
Quick Facts
What This Study Found
Bleomycin-induced pulmonary fibrosis in guinea pigs caused significantly increased expression of substance P, NK1R, CGRP, TRPA1, and TRPV1 in cough reflex pathways, all positively correlated with enhanced cough sensitivity to capsaicin challenge.
Key Numbers
TRPA1/TRPV1 upregulated in ganglia; SP/NK1R/CGRP upregulated in lung; positive correlation with cough sensitivity; NGF/NKA/NKB/BDNF also measured
How They Did This
Animal study. Bleomycin-induced pulmonary fibrosis guinea pig model. Cough sensitivity to capsaicin measured. Neuropeptide expression (SP, NK1R, CGRP) by immunohistochemistry and RT-qPCR. TRP channel expression by Western blot and RT-qPCR. Neurogenic factor concentrations by ELISA.
Why This Research Matters
Cough in IPF has no effective treatment. Identifying substance P, CGRP, and TRP channels as drivers opens the door to targeting these neuropeptides — potentially using existing drugs like NK1R antagonists or anti-CGRP antibodies — for a currently untreatable symptom.
The Bigger Picture
This connects neuropeptide biology to a devastating respiratory symptom. If substance P and CGRP drive fibrosis-related cough, existing anti-CGRP migraine drugs or NK1R antagonists could be repurposed — creating a therapeutic pathway where none currently exists.
What This Study Doesn't Tell Us
Guinea pig model — may not fully replicate human IPF cough. Bleomycin-induced fibrosis differs from naturally occurring IPF. Correlation between neuropeptides and cough doesn't prove causation. Small animal numbers likely.
Questions This Raises
- ?Would anti-CGRP antibodies used for migraine also reduce cough in IPF patients?
- ?Could NK1R antagonists like aprepitant provide cough relief in pulmonary fibrosis?
- ?Do human IPF patients have similarly elevated substance P and CGRP in their lungs?
Trust & Context
- Key Stat:
- Direct cough correlation Substance P, CGRP, TRPA1, and TRPV1 levels all positively correlated with cough sensitivity — the more neuropeptide, the worse the cough
- Evidence Grade:
- Moderate evidence: well-designed animal study with multiple measurement methods and consistent correlations, but limited to guinea pig model.
- Study Age:
- Published 2021. Research on neuropeptide-mediated cough continues, with anti-CGRP and anti-substance P approaches being explored.
- Original Title:
- Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model.
- Published In:
- BMC pulmonary medicine, 21(1), 187 (2021)
- Authors:
- Guan, Mengyue, Ying, Sun, Wang, Yuguang
- Database ID:
- RPEP-05421
Evidence Hierarchy
Frequently Asked Questions
Why do pulmonary fibrosis patients cough so much?
This study suggests that fibrotic lungs produce elevated levels of neuropeptides substance P and CGRP, which sensitize cough nerves (through TRPA1 and TRPV1 channels). This creates a vicious cycle of neurogenic inflammation and heightened cough sensitivity.
Could migraine drugs help with IPF cough?
Potentially. Anti-CGRP antibodies used for migraine target the same neuropeptide (CGRP) found elevated in fibrotic lungs. If human IPF cough is also CGRP-driven, these drugs might provide relief — though this hypothesis needs clinical testing.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05421APA
Guan, Mengyue; Ying, Sun; Wang, Yuguang. (2021). Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model.. BMC pulmonary medicine, 21(1), 187. https://doi.org/10.1186/s12890-021-01556-w
MLA
Guan, Mengyue, et al. "Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model.." BMC pulmonary medicine, 2021. https://doi.org/10.1186/s12890-021-01556-w
RethinkPeptides
RethinkPeptides Research Database. "Increased expression of transient receptor potential channel..." RPEP-05421. Retrieved from https://rethinkpeptides.com/research/guan-2021-increased-expression-of-transient
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.